Lunit INSIGHT CXR
by Lunit
AI-powered chest X-ray analysis software from Lunit that detects and localizes radiologic abnormalities, supporting clinicians in image interpretation and triage. It is offered as regulated medical software in multiple markets.
Why Abandoned
Lunit continues to list and support INSIGHT CXR on its official product website, and company materials describe ongoing commercial availability and regulatory clearances.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 94%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
Korean regulatory approval announced
Lunit announced that its chest X-ray AI software received approval from South Korea’s Ministry of Food and Drug Safety, enabling commercial use in Korea.
European CE marking announced
Lunit announced CE marking for Lunit INSIGHT CXR, supporting commercialization of the medical imaging software in Europe.
FDA clearance announced
Lunit announced U.S. FDA 510(k) clearance for Lunit INSIGHT CXR Triage, a version designed to flag suspected critical findings in chest X-rays.
Lunit completes KOSDAQ listing
Developer Lunit began trading on South Korea’s KOSDAQ market, raising capital to support its medical AI business and global expansion.
🔄 Alternatives to Lunit INSIGHT CXR
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Lunit INSIGHT CXR?
Lunit INSIGHT CXR is AI-based medical imaging software that analyzes chest radiographs, identifies suspected abnormalities, and presents their locations and confidence information to assist clinicians.
What can Lunit INSIGHT CXR detect on chest X-rays?
Its supported findings vary by product version and jurisdiction. Lunit’s product materials describe detection of common chest abnormalities such as nodules, consolidation, pneumothorax, pleural effusion, and other radiographic findings.
Is Lunit INSIGHT CXR FDA cleared?
Lunit has announced U.S. FDA 510(k) clearance for Lunit INSIGHT CXR Triage. Regulatory status and intended use depend on the specific version and country, so healthcare organizations should verify the applicable labeling.
How is Lunit INSIGHT CXR used in hospitals?
It can integrate with radiology workflows to analyze chest X-rays and surface suspected abnormalities or urgent cases. It is a decision-support tool and does not replace interpretation by a qualified healthcare professional.
Who makes Lunit INSIGHT CXR?
Lunit, a South Korean medical AI company founded in 2013, develops Lunit INSIGHT CXR as part of its diagnostic imaging product portfolio.